sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> tularemia market

report

Tularemia Market, by Type (Ulceroglandular Tularemia, Glandular Tularemia, Oculoglandular Tularemia, Oropharyngeal Tularemia, Pneumonic TularemiA, Others), Diagnosis (Microscopy, Immunochemistry, Others), Drugs (Streptomycin, Gentamicin, Doxycycline, Ciprofloxacin, Others), End-users (Hospitals and Clinics, Academic and Research Centres, Others) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC388 September 2017 100+ FREE 10% CUSTOMIZATION

Tularemia or deer fly fever or rabbit fever is a rare infectious disease mainly caused by the Francisella tularensis bacterium that affects eyes, lungs, skin and lymph nodes. It is mainly transmitted from different animals such as rabbits, rodents, and hares to human. It might also affect birds, cats, sheep, dogs, etc. The major cause of acquiring this infection is the direct bacteria exposure, insect bites, airborne infections, and bite of an animal infected through this disease. Tularemia is highly infectious and is widely used as a biological weapon by different countries such as Soviet Union and United States of America.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the tularemia market. The scope of this report covers the tularemia market by its major segments, which include the types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Factors that are increasing the Tularemia infection spread are exposure to sick, tick bites, or dead animals, specifically wild game. Travel to different areas such as Missouri, Arkansas and Oklahoma might cause this infection disease because of concentration ticks in those particular areas.
  • Tick bite is the major cause for the tularemia disease that are occurring with large no. of cases. More no. of laboratory workers are working with the risk of tularemia with airborne infection owing to enormous chances of pathogen exposure in the global market for tularemia.
  • This infection might also be airborne over period of sevrals works such as construction, gardening, or other activities, which might elad to pneumonic tularemia. Tularemia is also indentured by eating infected animal meat which is undercooked or drinking polluted water.

Regionally, the global tularemia market segmented into Europe, North America, Asia-Pacific, and the Rest of the World. Among these, North America region is the market leader in the global market for a tularemia with maximum no. of shares in the past few years. Availability of huge no. of manufacturers, the positive scenario of reimbursement and increasing healthcare expenditure are major factors for largest maximum market share for this particular region. However, Asia Pacific region is more likely to grow with a maximum market share in the years to come.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s tularemia market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the tularemia market by the following segments:

  • Tularemia Market, by Type
    • Ulceroglandular Tularemia
    • Glandular Tularemia
    • Oculoglandular Tularemia
    • Oropharyngeal Tularemia
    • Pneumonic TularemiA
    • Others
  • Tularemia Market, by Diagnosis
    • Microscopy
    • Immunochemistry
    • Others
  • Tularemia Market, by Drugs
    • Streptomycin
    • Gentamicin
    • Doxycycline
    • Ciprofloxacin
    • Others
  • Tularemia Market, by End-users
    • Hospitals and Clinics
    • Academic and Research Centres
    • Others

KEY MARKET PLAYERS

Key players in the tularemia market include:

  • Nicholas Piramal
  • Glaxo Smithkline
  • Bayer AG
  • Ranbaxy Laboratories
  • Glenmark Pharmaceuticals
  • Dr. Reddy's Lab,
  • Pfizer Inc.
  • Cipla Inc.
  • Lupin Limited
  • Zydus Cadila

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Healthcare Biometrics Market, by Applications (Patient Identification & Tracking, Medical Records Security & Data Centre Security, Home/Remote Patient Monitoring, Care Provider Authentication, Pharmacy Dispensing), Technology (Face Recognition, Iris Recognition, Hand Recognition, Voice Cognition, Fingerprint Recognition, Vein Recognition, Signature Recognition), End-Users (Hospital & Clinics, Healthcare Institutions, Research & Clinical Laboratories) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. TULAREMIA MARKET, BY TYPE
    1. Segment Share
    2. By Type
      1. Ulceroglandular Tularemia
      2. Glandular Tularemia
      3. Oculoglandular Tularemia
      4. Oropharyngeal Tularemia
      5. Pneumonic TularemiA
      6. Others
  6. TULAREMIA MARKET, BY DIAGNOSIS
    1. Segment Share
    2. By Diagnosis
      1. Microscopy
      2. Immunochemistry
      3. Others
  7. TULAREMIA MARKET, BY DRUGS
    1. Segment Share
    2. By Drugs
      1. Streptomycin
      2. Gentamicin
      3. Doxycycline
      4. Ciprofloxacin
      5. Others
  8. TULAREMIA MARKET, BY END-USERS
    1. Segment Share
    2. By End-user
      1. Hospitals and Clinics
      2. Academic and Research Centres
      3. Others
  9. TULAREMIA MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Type
      3. By Diagnosis
      4. By Drugs
      5. By End-users
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Type
      3. By Diagnosis
      4. By Drugs
      5. By End-users
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type
      3. By Diagnosis
      4. By Drugs
      5. By End-users
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Type
      3. By Diagnosis
      4. By Drugs
      5. By End-users
  10. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  11. KEY MARKET PLAYERS
    1. Nicholas Piramal
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Glaxo Smithkline
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Bayer AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Ranbaxy Laboratories
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Glenmark Pharmaceuticals
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Dr. Reddy's Lab,
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Pfizer Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Cipla Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Lupin Limited
      1. Overview
      2. Key Strategies
      3. Key Developments
    10. Zydus Cadila
      1. Overview
      2. Key Strategies
      3. Key Developments
  12. SCALAR 360 DEGREE MARKET PERSPECTIVE
  13. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us